Metastatic HER2-Positive Breast Cancer Market to Grow by 2032 at a 5.2% CAGR
The total metastatic HER2-positive breast cancer market size in the 7MM was estimated to be nearly USD 2.6 billion in 2022, which is expected to show positive...
Stay updated with breaking news from Oncopep Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The total metastatic HER2-positive breast cancer market size in the 7MM was estimated to be nearly USD 2.6 billion in 2022, which is expected to show positive...
/PRNewswire/ -- OncoPep, Inc. is proud to be a presenter at this year's Biotech Showcase January 9-11 in San Francisco. The company will be sending members of...
/PRNewswire/ -- OncoPep, Inc. is proud to be a participant at this year's BIO International Convention 2022 conference June 13-16 in San Diego CA. The company...
Metastatic Breast Cancer Pipeline involves 120+ key companies continuously working towards developing 120+ Metastatic B...
/PRNewswire/ -- OncoPep, Inc. has named Dr. Victor Moyo Chief Medical Officer effective May 9th. As CMO, Moyo will provide strategic clinical leadership to...